Key facts
- This page summarizes Amit Etkin's Form 4 filing for Alto Neuroscience, Inc. (ANRO).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 15 May 2026, 17:06.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Gift
Additional SEC filing notes
Footnote F1
The reporting person transferred 400,000 shares for estate planning purposes to the Bard on Haven Trust, an irrevocable trust, for the benefit of his spouse and children as a bona fide gift for no consideration. The trustee of the trust is independent of the reporting person, and the reporting person does not have voting, dispositive, or pecuniary interest over any of the securities held by the trust.